Press Releases

DTect-All(TM) platform will be used to screen for GPCR-directed allosteric modulator antibodies Strasbourg, France, February 4, 2014 – Domain Therapeutics, a biopharmaceutical company specializing in the research and development of new drug candidates targeting G protein-coupled receptors (GPCRs), today...

The agreement covers the creation and sale of rodent animal models, the sale of existing rodent animal models and sublicensing rightsParis, France, February 4, 2014 – Cellectis (Alternext: ALCLS), the genome engineering specialist, and genOway (Alternext: ALGEN), the animal...

TxCell SA, a clinical stage biotechnology company developing innovative, personalized cell-based immunotherapies using antigen-specific regulatory T-cells (Ag-Tregs) for chronic inflammatory and autoimmune diseases, announces today that Damian Marron, CEO, TxCell, will present at BIO CEO & Investor Conference 2014....

US-based pharmaceutical firm dedicated to the commercialization of oncology treatment and oncology supportive care products DARA BioSciences has signed a pharmacy supply agreement with RainTree Oncology Services. The agreement is for both Gelclair,...

Their joint aim is to identify new therapeutic targets in ‘triple negative’ breast cancers Paris and Suresnes, France, January 28, 2014 – Curie-Cancer, the body which leads the Institut Curie's industry partner research activity, and Servier, today announce that...

Study results provide positive data for ongoing human trials Reading and Oxford, UK, January 23, 2014 – Clasado, the manufacturers and suppliers of the second generation prebiotic Bimuno®, and The Department of Psychiatry, University of Oxford, today announce...

Canada-based Domain Therapeutics NA Inc. will focus exclusively on leveraging the BioSens-All(TM) technologyStrasbourg, France and Montreal, Canada, January 20, 2014 – Domain Therapeutics, a biopharmaceutical company specializing in the research and development of new drug candidates targeting G protein-coupled...